(2021). Gilteritinib/hydroxycarbamide/remdesivir: Neutropenia, lack of efficacy and off-label use: case report. Reactions Weekly.
Chicago Style Citation"Gilteritinib/hydroxycarbamide/remdesivir: Neutropenia, Lack of Efficacy and Off-label Use: Case Report." Reactions Weekly 2021.
Cita MLA"Gilteritinib/hydroxycarbamide/remdesivir: Neutropenia, Lack of Efficacy and Off-label Use: Case Report." Reactions Weekly 2021.
Atenció: Aquestes cites poden no estar 100% correctes.